你好,请登录   免费注册    |    收藏本站
联系电话: 0574-87917803
联系电话: call_new 0574-87917803
Lechevalieria aerocolonigenes (Labeda) Labeda et al.
Lechevalieria aerocolonigenes (Labeda) Labeda et al.
规格:
货期:
编号:TS207825
品牌:Testobio
产品名称: Lechevalieria aerocolonigenes (Labeda) Labeda et al.
商品货号: TS207825
Deposited As: Nocardia aerocolonigenes (Shinobu and Kawato) Pridham
Strain Designations: C-38383-RK2 DSM 44217
Application:
Produces 4-deschlororebeccamycin
Produces bromorebeccamycin
Produces rebeccamycin
Isolation:
Soil, Panama
Biosafety Level: 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format: freeze-dried
Disclosure: This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Preceptrol®: no
Type Strain: no
Comments:
Taxonomy
Glycosylation of indolopyrrolocarbazole derivatives
Medium: ATCC® Medium 196: Yeast malt extract agar
Growth Conditions:
Temperature: 26.0°C
Name of Depositor: JA Bush
U.S. Patent Number:
References:

Bush JA, et al. Production and biological activity of rebeccamycin, a novel antitumor agent. J. Antibiot. 40: 668-678, 1987. PubMed: 3112080

Matson JA. Process for preparing 4-deschlororebeccamycin. US Patent 4,567,143 dated Jan 28 1986

Labeda DP. Transfer of"Nocardia aerocolonigenes" (Sinobu and Kawato 1960) Pridham 1970 into the genus Saccharothrix Labeda, Testa, Lechevalier, and Lechevalier 1984 as Saccharothrix aerocolonigenes sp. nov.. Int. J. Syst. Bacteriol. 36: 109-110, 1986.

Lam KS, et al. Isolation of a bromo analog of rebeccamycin from Saccharothrix aerocolonigenes. J. Antibiot. 44: 934-939, 1991. PubMed: 1938615

Kojiri K, et al. Process for producing glycosylated indolopyrrolocarbazole derivatives by culturing certain microorganisms. US Patent 5,589,365 dated Dec 31 1996

首页 > 产品中心 > 微生物培养 > 菌株 > null > Lechevalieria aerocolonigenes (Labeda) Labeda et al.

Lechevalieria aerocolonigenes (Labeda) Labeda et al.

  • 货号: TS207825
  • 好评
询价
  • 品牌 : TESTOBIO
产品名称: Lechevalieria aerocolonigenes (Labeda) Labeda et al.
商品货号: TS207825
Deposited As: Nocardia aerocolonigenes (Shinobu and Kawato) Pridham
Strain Designations: C-38383-RK2 DSM 44217
Application:
Produces 4-deschlororebeccamycin
Produces bromorebeccamycin
Produces rebeccamycin
Isolation:
Soil, Panama
Biosafety Level: 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format: freeze-dried
Disclosure: This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Preceptrol®: no
Type Strain: no
Comments:
Taxonomy
Glycosylation of indolopyrrolocarbazole derivatives
Medium: ATCC® Medium 196: Yeast malt extract agar
Growth Conditions:
Temperature: 26.0°C
Name of Depositor: JA Bush
U.S. Patent Number:
References:

Bush JA, et al. Production and biological activity of rebeccamycin, a novel antitumor agent. J. Antibiot. 40: 668-678, 1987. PubMed: 3112080

Matson JA. Process for preparing 4-deschlororebeccamycin. US Patent 4,567,143 dated Jan 28 1986

Labeda DP. Transfer of"Nocardia aerocolonigenes" (Sinobu and Kawato 1960) Pridham 1970 into the genus Saccharothrix Labeda, Testa, Lechevalier, and Lechevalier 1984 as Saccharothrix aerocolonigenes sp. nov.. Int. J. Syst. Bacteriol. 36: 109-110, 1986.

Lam KS, et al. Isolation of a bromo analog of rebeccamycin from Saccharothrix aerocolonigenes. J. Antibiot. 44: 934-939, 1991. PubMed: 1938615

Kojiri K, et al. Process for producing glycosylated indolopyrrolocarbazole derivatives by culturing certain microorganisms. US Patent 5,589,365 dated Dec 31 1996

合作单位: